9th Clinical Biomarkers & World CDx Boston 2018 Summit is organized by Hanson Wade and will be held from Oct 02 - 05, 2018 at Renaissance Boston Waterfront Hotel, Boston, Massachusetts, United States of America.
Conference Description :
The four day meeting is split into two halves: pre-conference and main conference. Our pre-conference days will contain half-day workshop sessions, designed to take deep, interactive dives into a specific subject area. The main two day conference is separated into three streams covering translational development, clinical validation and implementation and drug-Dx commercialisation.
This course is once again the home for the biomarker, translational and diagnostic community to accelerate the translation from exploratory biomarker into clinically validated signature and ultimately a proven, predictive IVD.
As the place to be for the precision medicine field, Clinical Biomarkers & World CDx Boston covers end-to-end the development, clinical implementation and commercialization of a biomarker strategy to increase market penetration and market share for a targeted therapeutic. Ultimately, the meeting is here to streamline the path from R&D to providing patients with the right treatment decision and most effective therapies at the right time.
We have two overarching themes that underpin and flow through the whole meeting :
• Enhance the robust validation of next-generation predictive biomarker signatures to accelerate the development and approval of innovative targeted therapeutics.
• Improving the uptake of high value precision medicines and diagnostic testing to progress the standard of care for patients worldwide.
Time: 8:00 am to 4:00 pm
Additional details will be posted as soon as they are available.